Experience

General Inception

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Analyst

  • Oct 2022 - 1 year 3 months

  A position in the Life Science Tools and Diagnostics vertical to perform diligence on incoming opportunities

• Analyst

  • Aug 2022 - Sep 2022



University of Chicago

• United States
• Higher Education
• 700 & Above Employee

• Ph.D. Candidate

  • Jul 2018 - Sep 2022

  Chicago, Illinois, United States -Conceived, managed, and executed an independent research project studying the interactions between Yersinia pestis (bubonic plague) and the innate immune system -Studied functional activation of GPCRs, a major target for therapeutics, by Y. pestis and S. aureus -Developed an assay to biochemically characterize an essential enzyme from Yersinia pestis -Organized and maintained a mouse breeding colony generated by genetic engineering; contained 8 novel mouse strains -Presented… Show more -Conceived, managed, and executed an independent research project studying the interactions between Yersinia pestis (bubonic plague) and the innate immune system -Studied functional activation of GPCRs, a major target for therapeutics, by Y. pestis and S. aureus -Developed an assay to biochemically characterize an essential enzyme from Yersinia pestis -Organized and maintained a mouse breeding colony generated by genetic engineering; contained 8 novel mouse strains -Presented research yearly at departmental seminar; weekly to lab/PI; twice to broad audiences -Compiled and presented 5 lectures across 2 undergraduate courses as a teaching assistant -Utilized R and Python programming languages and Unix scripting for bioinformatic analyses

• PME Venture Fellow

  • Dec 2021 - Mar 2022

  Chicago, Illinois, United States -Performed diligence research on 5 biotechnologies - validated scientific merit, IP strength, research and development roadmap, and time-to-market for each technology -Worked through market analysis and product commercialization of a diagnostic technology as a part of the Lab-to-Launch course at UChicago Booth School of Business -Competed in the 2022 Social New Venture Challenge with CapsID, a startup seeking to commercialize this diagnostic technology



ARCH Venture Partners

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Intern

  • Apr 2022 - Aug 2022

  Chicago, Illinois, United States



SmartHealth Catalyzer, Inc.

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Diligence Intern

  • Sep 2021 - Dec 2021

  -Carried out diligence research on 10 biomedical technologies with commercialization potential – included therapeutics, medical devices, and diagnostics -Characterized scientific basis of technologies and clinical translatability of model systems -Defined target patient populations/market size -Assessed intellectual property strength and limitations through patent research -Investigated funding and technology strength of competing companies



UCSF Benioff Children's Hospital Oakland Research Institute

• Research Intern

  • May 2017 - May 2018

  Oakland, California, United States Brief Research Project Description: Tested the role of an N-terminal signal sequence within the Chlamydia trachomatis effector protein TARP as a degradation signal within eukaryotic host cells

• Undergraduate Student Researcher

  • May 2014 - May 2017

  Oakland, California, United States Brief Research Descriptions: -Examined the mechanisms utilized by Chlamydia trachomatis to successfully evade the innate immune response after host cell entry -Found and sequenced unresolved gaps in the genomes of several Chlamydia trachomatis strains -Multi-Locus Sequence Typed clinical Chlamydia trachomatis samples to observe the distribution of strains in various regions around the world